Aldeyra Therapeutics, Inc.

GOLDMAN SACHS GROUP INC ALDX

Report date

12/31/2025

Quarter

2025 Q4

Filed

3/25/2026

Shares

305,706

Value ($000)

1,584

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	3/25/2026	1,584	0.0%	305,706	12/31/2025
2025 Q3	11/14/2025	955	0.0%	182,943	9/30/2025
2025 Q2	8/14/2025	535	0.0%	139,614	6/30/2025
2025 Q1	6/27/2025	715	0.0%	124,365	3/31/2025
2024 Q4	2/11/2025	1,199	0.0%	240,334	12/31/2024
2024 Q3	11/14/2024	781	0.0%	144,828	9/30/2024
2024 Q2	8/13/2024	347	0.0%	104,927	6/30/2024
2024 Q1	5/15/2024	300	0.0%	91,717	3/31/2024
2023 Q4	5/14/2024	518	0.0%	147,480	12/31/2023
2023 Q3	5/15/2024	1,127	0.0%	168,683	9/30/2023
2023 Q2	5/14/2024	1,656	0.0%	197,436	6/30/2023
2023 Q1	5/14/2024	2,852	0.0%	287,243	3/31/2023
2022 Q4	5/14/2024	165	0.0%	23,750	12/31/2022
2022 Q3	5/14/2024	1,005	0.0%	188,307	9/30/2022
2022 Q2	5/14/2024	4,727	0.0%	1,184,584	6/30/2022
2022 Q1	5/16/2022	6,183	0.0%	1,391,018	3/31/2022
2021 Q4	2/17/2022	410	0.0%	102,665	12/31/2021
2021 Q3	1/20/2022	1,072	0.0%	122,055	9/30/2021
2021 Q2	8/13/2021	11,416	0.0%	1,007,619	6/30/2021
2021 Q1	5/17/2021	899	0.0%	75,647	3/31/2021
2020 Q4	2/12/2021	295	0.0%	42,935	12/31/2020
2020 Q3	11/13/2020	219	0.0%	29,561	9/30/2020
2020 Q2	8/12/2020	155	0.0%	37,073	6/30/2020
2020 Q1	5/15/2020	69	0.0%	27,949	3/31/2020
2019 Q4	2/14/2020	575	0.0%	99,073	12/31/2019